Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Updated Results From EPCORE NHL-1 - Effect of Follow-Up Time on the Ability of Subcutaneous Epcoritamab to Induce Deep & Durable CRs in Patients With R/R LBCL"

170 views
July 14, 2023
Comments 0
Login to view comments. Click here to Login